Nonmedical Costs of Colorectal Cancer Screening With the Fecal Occult Blood Test and Colonoscopy
Authors:
- Flora AuFAFlora Au
- Braden J. MannsBMBraden J. Manns
- S. Elizabeth McGregorSMS. Elizabeth McGregor
- Robert J. HilsdenRHRobert J. Hilsden
- 1 August 2008
- journal article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 6 (8) , 912-917.e1
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Computed tomographic colonography for colorectal screeningEndoscopy, 2007
- Emerging Technologies in Colorectal Cancer ScreeningSurgical Oncology Clinics of North America, 2005
- Correcting for compensating mechanisms related to productivity costs in economic evaluations of health care programmesHealth Economics, 2004
- Colorectal cancer screening: practices and opinions of primary care physiciansPreventive Medicine, 2004
- A Population-Based Estimate of the Extent of Colorectal Cancer Screening in OntarioAmerican Journal of Gastroenterology, 2004
- Colorectal cancer screening and surveillance: Clinical guidelines and rationale?Update based on new evidenceGastroenterology, 2003
- Randomised study of screening for colorectal cancer with faecal-occult-blood testThe Lancet, 1996
- Randomised controlled trial of faecal-occult-blood screening for colorectal cancerThe Lancet, 1996
- The friction cost method for measuring indirect costs of diseaseJournal of Health Economics, 1995
- Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult BloodNew England Journal of Medicine, 1993